Breaking News
Tulsi Gabbard Exposes Alarming Biden-Era 'Domestic Terrorism' Strategy
"Levitating Diamonds Reach Impossible Speed":
Talons From The Sky: Coiled Scales On The Ground
If You Could Destroy America: How Would You Do It?
Top Tech News
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Molten salt test loop to advance next-gen nuclear reactors
Quantum Teleportation Achieved Over Internet For The First Time
Watch the Jetson Personal Air Vehicle take flight, then order your own
Microneedles extract harmful cells, deliver drugs into chronic wounds
39-Year-Old Becomes First US Patient to Receive Innovative Artificial Heart Prosthetic
The artificial heart was developed by a French company, CARMAT and has been approved for use and sale in Europe.
Last year, the company received U.S. FDA approval to begin studies and enroll 10 patients with end-stage biventricular heart failure—people who are suffering on the waiting list for a heart donor—and offer a life-saving bridge before transplant.
"We are encouraged that our patient is doing so well after the procedure Monday," said Dr. Carmelo Milano, a transplant surgeon and the principal investigator of the device study at Duke. "As we evaluate this device, we are both excited and hopeful that patients who otherwise have few to no options could have a lifeline."
The North Carolina patient, Matthew Moore, is just 39-years-old and was referred to Duke in June after a sudden, unexpected diagnosis of heart failure. Moore and his wife, Rachel, recently adopted their two-year-old foster son, Marshall, and arrived at Duke expecting only to undergo heart bypass surgery.